Cancer Research Landon Prizes for Basic and Translational Cancer Research  AACR Conference on Molecular Diagnostics - 2008
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 26, 757-764, April 1, 1966]
© 1966 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Meisels, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Meisels, A.

Effect of Sex Hormones on the Carcinogenic Action of Dimethylbenzanthracene on the Uterus of Intact and Castrated Mice1

Alexander Meisels

Department of Pathology, Laval University, Quebec, Canada

An experimental model of uterine carcinogenesis by implantation of a pearl of pure dimethylbenzanthracene in contact with the cervix or the endometrium of mice was used to test the possible influence of sex hormones on the incidence of malignant lesions. Administered at relatively low, but physiologically active doses, estrogen significantly lowered the incidence of uterine cancer. Ovariectomy also significantly reduced the incidence of malignant uterine lesions. The group of castrated animals receiving estrogen had the lowest incidence of the whole series. These results suggest the possibility that ovariectomy removes the site of synthesis of a promoting agent in this experimental model—conceivably progesterone.

1 This work was supported by a grant from the National Cancer Institute of Canada.

Received 5/20/65. Revised 9/ 9/65.





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1966 by the American Association for Cancer Research.